Growth Metrics

Thermo Fisher Scientific (TMO) Non-Current Deferred Tax Liability (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Non-Current Deferred Tax Liability for 16 consecutive years, with $1.1 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Non-Current Deferred Tax Liability fell 57.14% year-over-year to $1.1 billion, compared with a TTM value of $1.1 billion through Sep 2024, down 57.14%, and an annual FY2023 reading of $1.9 billion, down 32.54% over the prior year.
  • Non-Current Deferred Tax Liability was $1.1 billion for Q3 2024 at Thermo Fisher Scientific, down from $1.5 billion in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $3.8 billion in Q4 2021 and bottomed at $1.1 billion in Q3 2024.
  • Average Non-Current Deferred Tax Liability over 5 years is $2.3 billion, with a median of $1.9 billion recorded in 2023.
  • The sharpest move saw Non-Current Deferred Tax Liability surged 114.33% in 2022, then tumbled 57.14% in 2024.
  • Year by year, Non-Current Deferred Tax Liability stood at $1.8 billion in 2020, then surged by 113.88% to $3.8 billion in 2021, then fell by 25.75% to $2.8 billion in 2022, then crashed by 32.54% to $1.9 billion in 2023, then tumbled by 41.57% to $1.1 billion in 2024.
  • Business Quant data shows Non-Current Deferred Tax Liability for TMO at $1.1 billion in Q3 2024, $1.5 billion in Q2 2024, and $1.8 billion in Q1 2024.